Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label single-arm study of enarodustat in peritoneal dialysis patients with renal anemia due to chronic kidney disease
CTR20234236Phase 3Active
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enarodustat in Uraemic Anaemia, sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Dec 2023; status: active.
02
Drugs
enarodustat
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on CTR20234236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234236.